Advertisement

Index by author

October 01, 2011; Volume 339,Issue 1

  1. Takahashi, Shuhei

    1. Nonsteroidal Anti-Inflammatory Drug Flufenamic Acid Is a Potent Activator of AMP-Activated Protein Kinase
      Yuan Chi, Kai Li, Qiaojing Yan, Schuichi Koizumi, Liye Shi, Shuhei Takahashi, Ying Zhu, Hiroyuki Matsue, Masayuki Takeda, Masanori Kitamura and Jian Yao
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 257-266; DOI: https://doi.org/10.1124/jpet.111.183020

  2. Takai, Shinji

    1. Chymase Inhibition Reduces Infarction and Matrix Metalloproteinase-9 Activation and Attenuates Inflammation and Fibrosis after Acute Myocardial Ischemia/Reperfusion
      Shizu Oyamada, Cesario Bianchi, Shinji Takai, Louis M. Chu and Frank W. Sellke
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 143-151; DOI: https://doi.org/10.1124/jpet.111.179697

  3. Takeda, Masayuki

    1. Nonsteroidal Anti-Inflammatory Drug Flufenamic Acid Is a Potent Activator of AMP-Activated Protein Kinase
      Yuan Chi, Kai Li, Qiaojing Yan, Schuichi Koizumi, Liye Shi, Shuhei Takahashi, Ying Zhu, Hiroyuki Matsue, Masayuki Takeda, Masanori Kitamura and Jian Yao
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 257-266; DOI: https://doi.org/10.1124/jpet.111.183020

  4. Takeuchi, Koji

    1. TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats
      Yoshiyuki Tsujihata, Ryo Ito, Masami Suzuki, Ayako Harada, Nobuyuki Negoro, Tsuneo Yasuma, Yu Momose and Koji Takeuchi
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 228-237; DOI: https://doi.org/10.1124/jpet.111.183772

  5. Teng, Bao

    1. Role of Vimentin in the Inhibitory Effects of Low-Molecular-Weight Heparin on PC-3M Cell Adhesion to, and Migration through, Endothelium
      Yan Pan, Tianluo Lei, Bao Teng, Jihong Liu, Jianzhao Zhang, Yu An, Yuan Xiao, Jing Han, Xueyang Pan, Junhua Wang, Heming Yu, Hong Ren and Xuejun Li
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 82-92; DOI: https://doi.org/10.1124/jpet.111.182055

  6. Testar, Richard J.

    1. Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs
      Lindsey A. Needham, Alan H. Davidson, Lindsay J. Bawden, Andrew Belfield, Elisabeth A. Bone, Deborah H. Brotherton, Sam Bryant, Michael H. Charlton, Vanessa L. Clark, Stephen J. Davies, Alastair Donald, Francesca A. Day, David Krige, Valérie Legris, Joanne McDermott, Yvonne McGovern, Jo Owen, Sanjay R. Patel, Stéphane Pintat, Richard J. Testar, Graham M. A. Wells, David Moffat and Alan H. Drummond
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 132-142; DOI: https://doi.org/10.1124/jpet.111.183640

  7. Thompson, A. J.

    1. Varenicline Is a Potent Agonist of the Human 5-Hydroxytryptamine3 Receptor
      S. C. R. Lummis, A. J. Thompson, M. Bencherif and H. A. Lester
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 125-131; DOI: https://doi.org/10.1124/jpet.111.185306

  8. Tsuchiya, Masato

    1. Glycyrrhizin Prevents Liver Injury by Inhibition of High-Mobility Group Box 1 Production by Kupffer Cells after Ischemia-Reperfusion in Rats
      Masahito Ogiku, Hiroshi Kono, Michio Hara, Masato Tsuchiya and Hideki Fujii
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 93-98; DOI: https://doi.org/10.1124/jpet.111.182592

  9. Tsujihata, Yoshiyuki

    1. TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats
      Yoshiyuki Tsujihata, Ryo Ito, Masami Suzuki, Ayako Harada, Nobuyuki Negoro, Tsuneo Yasuma, Yu Momose and Koji Takeuchi
      Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 228-237; DOI: https://doi.org/10.1124/jpet.111.183772
Back to top

In this issue

Advertisement